News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LipoScience, Inc. Hits Reset Button on New Blood Test


8/29/2013 9:06:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A management shakeup isn’t the only issue facing Raleigh diagnostics firm LipoScience (Nasdaq: LPDX), which once again finds itself at odds with the Food and Drug Administration. The newly public company is voluntarily withdrawing its application to market a new blood test, but isn’t giving up on the product. Specifically, LipoScience is withdrawing its 510 (k) filing to market a high-density lipoprotein particle (HDL-P) test, which measures certain blood particles in order to better manage heart disease.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES